Replies to post #65736 on Biotech Values

[DewDiligence]

SCRX (30.68) closed at a mere 1% discount to the $31 buyout price. Evidently, some investors are expecting a sweeter offer from Shionogi or another party.

[microcapfun]

>>Yet Another “Cheap Dollar” Buyout<<

Is the end near?

http://www.forecasts.org/images/exchange-rate/euro.gif

I think bio buyouts have been fueled by three things: 1. Big Pharma pipeline problems. 2. Cheap dollar. 3. Big Pharma cash hordes.

The first is still providing strong impetus, but the dollar is becoming less cheap and maybe Pharmas are beginning to deplete their cash.

Comments?

micro